Reduction of Left Ventricular Dilation Beyond the First Year After Anterior Myocardial Infarction

Jaume Figueras1, Jordi BaÑeras1, Santiago AguadÉ1

  • 1Unitat Coronària, Servei de Cardiologia and Servei de Medicina Nuclear, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Insights

Left ventricular (LV) dilation reduction occurred in 21% of ST-segment-elevation myocardial infarction (STEMI) survivors by 3 years. This reduction was linked to improved ejection fraction, regardless of initial LV dilation severity.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Medical Imaging

Background:

  • The long-term impact of ST-segment-elevation myocardial infarction (STEMI) on left ventricular (LV) remodeling is complex.
  • Understanding the potential for reduction in LV dilation (RD) beyond the first year post-STEMI is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the occurrence of LV dilation reduction (RD) between 1 and 3 years after anterior STEMI.
  • To compare RD with stationary dilation (SD) and progressive dilation (PD) in STEMI survivors.
  • To identify factors associated with LV dilation changes post-STEMI.

Main Methods:

  • Evaluated perfusion gated SPECT in 168 three-year survivors of a first anterior STEMI.
  • Categorized patients into RD (≥15% LV end-systolic volume reduction), SD (<15% change), and PD (≥15% increase).
  • Assessed LV volumes, ejection fraction, and wall motion at 1 and 3 years post-STEMI.

Main Results:

  • 21% of patients exhibited RD, 50% SD, and 29% PD at 3 years.
  • LV dilation reduction was observed in patients with both significant and moderate LV dilation at 1 year.
  • LV dilation reduction was associated with improved ejection fraction, irrespective of baseline LV volumes at 1 year.

Conclusions:

  • Approximately 21% of anterior STEMI patients experience a reduction in LV dilation by 3 years.
  • This late reduction in LV dilation is associated with improved ejection fraction.
  • These findings suggest potential for late LV remodeling changes and possibly late infarct size modification.
Abstract

Related Concept Videos

Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

Oxidation–Reduction Reactions
75.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
536
Muscles of the Anterior Neck01:26

Muscles of the Anterior Neck

The anterior neck muscles are the group of muscles covering the front part of the neck. These muscles are classified into three subgroups. The first one is the superficial muscles, the most visible muscles in the front of the neck. It includes the platysma and sternocleidomastoid. The second group is the suprahyoid muscles, located above the hyoid bone. This group comprises the digastric, mylohyoid, geniohyoid, and stylohyoid. Lastly, the infrahyoid muscles are found below the hyoid bone and...
4.7K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
548
Oxymercuration-Reduction of Alkenes02:36

Oxymercuration-Reduction of Alkenes

Oxymercuration–reduction of alkenes is one of the major reactions converting alkenes to alcohols. It involves the hydration of alkenes with mercuric acetate in a mixture of tetrahydrofuran and water, forming an organomercury adduct. This is followed by a demercuration step in which the adduct is reduced to an alcohol using sodium borohydride.
9.3K
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
584